Under new corporate social responsibility norms, companies spend '163 crore more than the requirement
GN Bureau | November 8, 2016
The spending under corporate social responsibility (CSR) by the NSE listed companies has seen a huge increase of 28 percent in 2015-16. The Companies Act (2013) has statutory provisions, making CSR mandatory for companies with net worth of Rs 500 crore or more, turnover of at least Rs 1,000 crore or net profit of at least Rs 5 crore. Such companies are required to spend at least 2 percent of their average net profits of last three years on CSR activities, while constituting a separate committee on their board. The law, implemented from April 2014, makes India the only country with a legislated CSR.
According to Prime Database, which has done the analysis, the average net profit of the 920 listed companies over last 3 years was Rs 4.60 lakh crore. As per the CSR provision, the companies were required to spend Rs 9,146 crore. The companies, however, spent Rs 9,309 crore, which is Rs 163 crore more than the requirement.
The Business Of Business Is (Not) Just Business: How Behavioural Tools Can Drive Real Change Edited by Sutapa Banerjee, with Foreword by Nadir Godrej HarperCollins, 336 pages, Rs 699
A small pharmacist in Rajkot neglects to change a notice in his store under a little-known clause of a public health law. This was not only a non-compliance matter, but also a criminal offence, and a jail sentence was the punishment under the old system. Not a fine. Not a warning. Jail. Now scale
Indian cities are growing at a pace that our infrastructure and climate can no longer sustain. This rapid urban sprawl increasingly strains urban systems, overshadowing the severe environmental fallout produced in its wake. The repercussions include Urban Heat Island Effect (UHI), Urban Floods, and many mo
A week after Donald Trump’s visit to China – the first by an American president in nine years, US secretary of state Marco Rubio arrived in India on May 23 on a four-day visit aimed at resetting Washington DC’s relations with New Delhi and attending the third Quad ministerial meeting.
India’s pharmaceutical industry stands as one of the world’s market leaders of generic pharmacy with market valuation of USD 50 billion in 2026. Characterised by high volume, low-cost generic manufacturing, with an annual growth rate of 10-12% primarily propelled by exports and domestic demand,
Robin Hood of Kathiawar and Other Extraordinary Stories from India’s Freedom Movement By The Paperclip HarperCollins, 348 pages, Rs 499
